BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 33755028)

  • 1. A Therapeutic Relational Agent for Reducing Problematic Substance Use (Woebot): Development and Usability Study.
    Prochaska JJ; Vogel EA; Chieng A; Kendra M; Baiocchi M; Pajarito S; Robinson A
    J Med Internet Res; 2021 Mar; 23(3):e24850. PubMed ID: 33755028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized controlled trial of a therapeutic relational agent for reducing substance misuse during the COVID-19 pandemic.
    Prochaska JJ; Vogel EA; Chieng A; Baiocchi M; Maglalang DD; Pajarito S; Weingardt KR; Darcy A; Robinson A
    Drug Alcohol Depend; 2021 Oct; 227():108986. PubMed ID: 34507061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A relational agent for treating substance use in adults: Protocol for a randomized controlled trial with a psychoeducational comparator.
    Prochaska JJ; Vogel EA; Chieng A; Baiocchi M; Pajarito S; Pirner M; Darcy A; Robinson A
    Contemp Clin Trials; 2023 Apr; 127():107125. PubMed ID: 36813084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility, Acceptability, and Potential Efficacy of a Self-Guided Internet-Delivered Dialectical Behavior Therapy Intervention for Substance Use Disorders: Randomized Controlled Trial.
    Daros AR; Guimond TH; Yager C; Palermo EH; Wilks CR; Quilty LC
    JMIR Ment Health; 2024 Jan; 11():e50399. PubMed ID: 38227362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivering Cognitive Behavior Therapy to Young Adults With Symptoms of Depression and Anxiety Using a Fully Automated Conversational Agent (Woebot): A Randomized Controlled Trial.
    Fitzpatrick KK; Darcy A; Vierhile M
    JMIR Ment Health; 2017 Jun; 4(2):e19. PubMed ID: 28588005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility, Acceptability, and Preliminary Efficacy of a Smartphone App-Led Cognitive Behavioral Therapy for Depression Under Therapist Supervision: Open Trial.
    Wilhelm S; Bernstein EE; Bentley KH; Snorrason I; Hoeppner SS; Klare D; Greenberg JL; Weingarden H; McCoy TH; Harrison O
    JMIR Ment Health; 2024 Apr; 11():e53998. PubMed ID: 38592771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographic and clinical characteristics associated with anxiety and depressive symptom outcomes in users of a digital mental health intervention incorporating a relational agent.
    Chiauzzi E; Williams A; Mariano TY; Pajarito S; Robinson A; Kirvin-Quamme A; Forman-Hoffman V
    BMC Psychiatry; 2024 Jan; 24(1):79. PubMed ID: 38291369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Personalized Approach Bias Modification Smartphone App ("SWiPE") to Reduce Alcohol Use: Open-Label Feasibility, Acceptability, and Preliminary Effectiveness Study.
    Manning V; Piercy H; Garfield JBB; Clark SG; Andrabi MN; Lubman DI
    JMIR Mhealth Uhealth; 2021 Dec; 9(12):e31353. PubMed ID: 34890355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Integrated Intervention for Dual Problems and Early Action Among Latino Immigrants With Co-occurring Mental Health and Substance Misuse Symptoms: A Randomized Clinical Trial.
    Alegría M; Falgas-Bague I; Collazos F; Carmona Camacho R; Lapatin Markle S; Wang Y; Baca-García E; Lê Cook B; Chavez LM; Fortuna L; Herrera L; Qureshi A; Ramos Z; González C; Aroca P; Albarracín García L; Cellerino L; Villar A; Ali N; Mueser KT; Shrout PE
    JAMA Netw Open; 2019 Jan; 2(1):e186927. PubMed ID: 30646205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of the Minder Mobile Mental Health and Substance Use Intervention for University Students: Randomized Controlled Trial.
    Vereschagin M; Wang AY; Richardson CG; Xie H; Munthali RJ; Hudec KL; Leung C; Wojcik KD; Munro L; Halli P; Kessler RC; Vigo DV
    J Med Internet Res; 2024 Mar; 26():e54287. PubMed ID: 38536225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chatbot-Delivered Cognitive Behavioral Therapy in Adolescents With Depression and Anxiety During the COVID-19 Pandemic: Feasibility and Acceptability Study.
    Nicol G; Wang R; Graham S; Dodd S; Garbutt J
    JMIR Form Res; 2022 Nov; 6(11):e40242. PubMed ID: 36413390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility and impact of a mental health chatbot on postpartum mental health: a randomized controlled trial.
    Suharwardy S; Ramachandran M; Leonard SA; Gunaseelan A; Lyell DJ; Darcy A; Robinson A; Judy A
    AJOG Glob Rep; 2023 Aug; 3(3):100165. PubMed ID: 37560011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engagement, Satisfaction, and Mental Health Outcomes Across Different Residential Subgroup Users of a Digital Mental Health Relational Agent: Exploratory Single-Arm Study.
    Forman-Hoffman VL; Pirner MC; Flom M; Kirvin-Quamme A; Durden E; Kissinger JA; Robinson A
    JMIR Form Res; 2023 Sep; 7():e46473. PubMed ID: 37756047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobile app-based chatbot to deliver cognitive behavioral therapy and psychoeducation for adults with attention deficit: A development and feasibility/usability study.
    Jang S; Kim JJ; Kim SJ; Hong J; Kim S; Kim E
    Int J Med Inform; 2021 Jun; 150():104440. PubMed ID: 33799055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of a Web-based and Mobile Therapy Chatbot on Anxiety and Depressive Symptoms in Subclinical Young Adults: Randomized Controlled Trial.
    Karkosz S; Szymański R; Sanna K; Michałowski J
    JMIR Form Res; 2024 Mar; 8():e47960. PubMed ID: 38506892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Relational Agent Intervention for Adolescents Seeking Mental Health Treatment: Protocol for a Randomized Controlled Trial.
    Chiauzzi E; Robinson A; Martin K; Petersen C; Wells N; Williams A; Gleason MM
    JMIR Res Protoc; 2023 Mar; 12():e44940. PubMed ID: 36867455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis Use in Adults Who Screen Positive for Attention Deficit/Hyperactivity Disorder: CANreduce 2.0 Randomized Controlled Trial Subgroup Analysis.
    Ahlers J; Baumgartner C; Augsburger M; Wenger A; Malischnig D; Boumparis N; Berger T; Stark L; Ebert DD; Haug S; Schaub MP
    J Med Internet Res; 2022 Apr; 24(4):e30138. PubMed ID: 35442196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of an Artificial Intelligence Platform for Behavioral Interventions on Depression and Anxiety Symptoms: Randomized Clinical Trial.
    Sadeh-Sharvit S; Camp TD; Horton SE; Hefner JD; Berry JM; Grossman E; Hollon SD
    J Med Internet Res; 2023 Jul; 25():e46781. PubMed ID: 37428547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in stress, burnout, and resilience associated with an 8-week intervention with relational agent "Woebot".
    Durden E; Pirner MC; Rapoport SJ; Williams A; Robinson A; Forman-Hoffman VL
    Internet Interv; 2023 Sep; 33():100637. PubMed ID: 37635948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usability and Acceptability of a Mobile App for the Self-Management of Alcohol Misuse Among Veterans (Step Away): Pilot Cohort Study.
    Malte CA; Dulin PL; Baer JS; Fortney JC; Danner AN; Lott AMK; Hawkins EJ
    JMIR Mhealth Uhealth; 2021 Apr; 9(4):e25927. PubMed ID: 33830064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.